Case report identifies hybrid adenoid cystic carcinoma with unique features in a 50-year-old female, suggesting need for further research.
Adenoid cystic carcinoma (ACC) is a rare, slowly growing salivary gland neoplasm distinguished by its versatile phenotype and destructive clinical course. Its underlying aetiology is unclear. It is characterised by a gradual yet infiltrative progression, perineural invasion (PNI), a worse prognosis, late recurrence and distant metastases. ACC is recognised for its unique histological features and susceptibility to PNI. We present a case of a female in her 50s with a history of progressively enlarging swelling in the right palate diagnosed as a “hybrid variant of adenoid cystic carcinoma”. Histopathological analysis confirmed the diagnosis, emphasising the need for long-term follow-up given ACC’s propensity for late recurrence and distant spread, particularly to the lungs. For individuals with advanced non-resectable, recurring and/or metastatic illness, there is currently no viable treatment. But its prevalence impedes the advancement of additional studies and clinical investigations to study new approaches and novel treatments.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: